Purinergic Regulation of Respiratory DiseasesMaryse Picher, Richard C. Boucher Springer Science & Business Media, 11 мая 2011 г. - Всего страниц: 282 We proudly present the first book to integrate all aspects of purinergic signaling in the respiratory system. The first chapters introduce basic notions of purinergic pharmacology and metabolism, which allows readers from all scientific backgrounds to fully grasp the importance of these signaling networks for airway defenses, including mucociliary clearance and inflammatory responses. Then, chapters are devoted to the groundbreaking discovery that chronic respiratory diseases, including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD), present specific aberrances in purinergic signaling which essentially drive lung complications. The last chapters describe the animal models used to investigate purinergic signaling in respiratory diseases, and the therapeutic applications developed by the pharmaceutical industry based on receptor agonists/antagonists and metabolic correctors. This highly comprehensive manuscript constitutes an invaluable tool for beginners and experts to follow the rapidly evolving research field of purinergic signaling. Furthermore, the critical analysis of past clinical protocols should facilitate the identification of potent therapeutic targets, and provide a better understanding of the data acquired in current clinical trials. |
Содержание
1 | |
Mechanisms Regulating Airway Nucleotides | 17 |
Computational Model for the Regulation of Extracellular ATP and Adenosine in Airway Epithelia | 50 |
Regulation of Airway Nucleotides in Chronic Lung Diseases | 75 |
NucleotideMediated Airway Clearance | 95 |
Purinergic Signaling in Wound Healing and Airway Remodeling | 139 |
Purinergic Regulation of Airway Inflammation | 158 |
Animal Models of Airway Diseases | 195 |
Therapeutic Applications | 235 |
277 | |
Другие издания - Просмотреть все
Purinergic Regulation of Respiratory Diseases Maryse Picher,Richard C. Boucher Недоступно для просмотра - 2011 |
Purinergic Regulation of Respiratory Diseases Maryse Picher,Richard C. Boucher Недоступно для просмотра - 2013 |
Purinergic Regulation of Respiratory Diseases Maryse Picher,Richard C. Boucher Недоступно для просмотра - 2011 |
Часто встречающиеся слова и выражения
A1Rs A2AR A2BRs accumulation actin activation acute lung injury addition adenosine ADO concentrations agonists airway epithelia alveolar antagonists apical associated asthma ATP release barrier Biol Chem Boeynaems Boucher RC bronchial Ca2+ caused channel Chap chronic clearance clinical concentrations conducted COPD cultures cystic fibrosis demonstrated diseases ectonucleotidases effects endothelial enzyme epithelial cells evidence experimental expression extracellular factor Ferrari fluid function goblet cells human airway identified immune important increase induced infection inflammation inflammatory inhibition inhibitors initiates involved levels lung mechanism mediated membrane mice migration neutrophils normal nucleotides pathways patients Pharmacol Physiol plasma prevent production promote protein pulmonary purinergic purinergic signaling purines recently receptor reduced regulation reported Respir respiratory responses role selective showed signaling steady-state stimulation studies subjects suggest surface therapeutic tion tissue transport treatment up-regulation